| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/10/2001 | DE19951795A1 Verwendung von Parvoviren zur Verbesserung des Allgemeinzustandes bei Tumorpatienten oder Patienten mit chronischen oder konsumierenden Erkrankungen Use of parvoviruses to improve the general condition in cancer patients or patients with chronic or consumptive diseases |
| 05/10/2001 | DE19949860A1 Clear salve for treating psoriasis, neurodermatitis and fungi comprises vaseline, juniper tar, 7.% walnut oil and almond oil |
| 05/10/2001 | CA2390180A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 05/10/2001 | CA2390053A1 Augmentation and repair of age-related soft tissue defects |
| 05/10/2001 | CA2389964A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/10/2001 | CA2389693A1 Dna-vaccines based on constructs derived from the genomes of human and animal pathogens |
| 05/10/2001 | CA2389690A1 Selective toxin expression in angiogenic endothelial cells |
| 05/10/2001 | CA2389646A1 Propagation of human hepatocytes in non-human animals |
| 05/10/2001 | CA2389415A1 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 05/10/2001 | CA2389335A1 Gene expression directed by a super-psa promoter |
| 05/10/2001 | CA2389283A1 Methods for preparing blood or plasma component solutions with improved concentrations |
| 05/10/2001 | CA2388354A1 Lactobacillus helvetius producing antihypertensive di- and tripeptides |
| 05/10/2001 | CA2388028A1 Method of inactivating pathogens |
| 05/10/2001 | CA2387808A1 Human chemokine beta-13 |
| 05/10/2001 | CA2387754A1 10 human secreted proteins |
| 05/10/2001 | CA2386641A1 32 human secreted proteins |
| 05/09/2001 | EP1097945A2 Monoclonal and chimeric antibody specific for human tumor necrosis factor |
| 05/09/2001 | EP1097942A2 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes |
| 05/09/2001 | EP1097715A1 Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient |
| 05/09/2001 | EP1097714A1 Composition for use in the treatment of tumours and the immunization of humans and animals |
| 05/09/2001 | EP1097200A1 Pharmaceutical uses of nab1 and nab2 |
| 05/09/2001 | EP1097193A1 Liver stem cell |
| 05/09/2001 | EP1096962A1 Method of obscuring immune recognition |
| 05/09/2001 | EP1096958A1 Irradiation of a liquid in a rotating cylinder |
| 05/09/2001 | EP1096942A2 Use of a medicine containing a quantity of tyrothricine for the treatment of viral infections |
| 05/09/2001 | EP1096941A1 Bone marrow cells as a source of neurons for brain and spinal cord repair |
| 05/09/2001 | EP0744892A4 Controlling donor blood characteristics |
| 05/09/2001 | EP0684842B1 Composition for use in the treatment of tumours and the immunization of humans and animals |
| 05/09/2001 | CN1294016A Injection for giving up addiction |
| 05/09/2001 | CN1294015A Medicine for treating thyroid enlargement and thyroidism |
| 05/09/2001 | CN1294014A Medicine for treating mastoplasia |
| 05/09/2001 | CN1294013A Medicine for treating prostatic hyperplasia |
| 05/09/2001 | CN1294011A 'Gumeihuichun Dan' |
| 05/09/2001 | CN1294007A Medicine for treating bone fracture and osteopathy |
| 05/09/2001 | CN1294005A Process for preparing health-care medicine |
| 05/09/2001 | CN1294001A Uropoly acid-peptide composition |
| 05/09/2001 | CN1294000A Process for preparing uropoly acid-peptide composition |
| 05/09/2001 | CN1293999A Chinese medicine for detoxicating wound and its preparing process |
| 05/09/2001 | CN1293998A Chinese medicine for treating diseases of cervical or lumbar vertebra |
| 05/09/2001 | CN1293995A Medicine for treating woman's acyesis |
| 05/09/2001 | CN1293992A Medicine 'Buyuan Jianmei Wan' |
| 05/09/2001 | CN1293989A Liquid Chinese medicine for treating rheumatism |
| 05/09/2001 | CN1293988A Chinese medicine 'Shexianfengshi wan' |
| 05/09/2001 | CN1293979A Medicine for quickly dropping drug |
| 05/09/2001 | CN1293975A Chinese patent medicine for treating nephrosis |
| 05/09/2001 | CN1293966A Health-care product for improving sleep |
| 05/09/2001 | CN1293965A Natural drug-dropping medicine |
| 05/09/2001 | CN1293960A Antivirus compound medicine |
| 05/09/2001 | CN1293959A Uropoly aic-peptide composition and its usage |
| 05/09/2001 | CN1293958A Method and equipment for storage of biological materials |
| 05/09/2001 | CN1065567C Lactobacillus used to enhance immunological functions |
| 05/09/2001 | CN1065431C Method for producing active doe placenta powder and products thereof |
| 05/08/2001 | US6228995 Removing psorlen or degradation products by contacting blood or blood products with absorbent beads or fibers including ion exchange resins, polystyrene, or polystyrene copolymerized with divinylbenzene; then collecting blood |
| 05/08/2001 | US6228644 Nucleotide and amino acid sequences; for transgenic plants with disease resistance, enhanced growth, and/or insect control |
| 05/08/2001 | US6228631 Recombinant α-N-acetylgalactosaminidase enzyme and cDNA encoding said enzyme |
| 05/08/2001 | US6228619 Glucosaminidase |
| 05/08/2001 | US6228617 Nucleotide sequence coding a trigger chaperone protein; for use in screening bactericides |
| 05/08/2001 | US6228584 Nucleotide sequences for use in the detection of streptococcus |
| 05/08/2001 | US6228359 Treatment of autoimmune diseases by removal of cells and inhibitors |
| 05/08/2001 | US6228358 Method of producing fermented milk containing manganese and tea |
| 05/08/2001 | US6227202 Method of organogenesis and tissue regeneration/repair using surgical techniques |
| 05/08/2001 | US6227195 Coarse spray delivery of functional biologic material |
| 05/08/2001 | CA2214933C Herbal salve |
| 05/08/2001 | CA2096010C Recombinant feline coronavirus s proteins |
| 05/03/2001 | WO2001031343A2 Diagnosis and therapy of cancer using sgp28-related molecules |
| 05/03/2001 | WO2001031058A2 Identification of cells for transplantation |
| 05/03/2001 | WO2001031046A1 Invasive bacterial vectors for expressing alphavirus replicons |
| 05/03/2001 | WO2001031036A2 Modified viral surface proteins which bind to cells of tumor vasculature |
| 05/03/2001 | WO2001031015A2 36p6d5: secreted tumor antigen |
| 05/03/2001 | WO2001031003A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 05/03/2001 | WO2001030982A1 Olfactory ensheathing cells isolated from the lamina propria |
| 05/03/2001 | WO2001030981A1 Cultures of gfap?+ nestin+¿ cells that differentiate to neurons |
| 05/03/2001 | WO2001030980A2 Methods and compositions for enhancing developmental potential of oocytes and zygotes |
| 05/03/2001 | WO2001030978A1 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 05/03/2001 | WO2001030848A2 Nucleic acids of the human abc1 gene and applications thereof |
| 05/03/2001 | WO2001030847A1 Modified gp100 and uses thereof |
| 05/03/2001 | WO2001030843A1 Ligand activated transcriptional regulator proteins |
| 05/03/2001 | WO2001030802A2 Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies |
| 05/03/2001 | WO2001030754A2 Micro-cluster liquids and methods of making and using them |
| 05/03/2001 | WO2001030382A1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 05/03/2001 | WO2001030381A2 Use of csf-1 inhibitors |
| 05/03/2001 | WO2001030375A2 Use of gdnf for treating corneal defects |
| 05/03/2001 | WO2001030366A2 Use of parvoviruses for improving the general condition of tumour patients or patients having chronic or consumptive diseases |
| 05/03/2001 | WO2001030365A1 Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis |
| 05/03/2001 | WO2001030364A1 Method and apparatus for processing blood and blood components |
| 05/03/2001 | WO2001030362A2 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 05/03/2001 | WO2001014530A3 Method for growing stem cells |
| 05/03/2001 | WO2000074712A3 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 05/03/2001 | WO2000065028A3 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 05/03/2001 | WO2000054813A3 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| 05/03/2001 | US20010000802 Implantable system with drug-eluting cells for on-demand local drug delivery |
| 05/03/2001 | DE10039856A1 Inducing cell replication in resting cells, useful for producing cells for e.g. toxicology testing, by transient expression of immortalizing gene |
| 05/03/2001 | CA2721011A1 Modified gp100 and uses thereof |
| 05/03/2001 | CA2389522A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 05/03/2001 | CA2389121A1 Olfactory ensheathing cells isolated from the lamina propria |
| 05/03/2001 | CA2389117A1 Methods and compositions for enhancing developmental potential of oocytes and zygotes |
| 05/03/2001 | CA2388950A1 Nucleic acids of the human abc1 gene and their therapeutic and diagnostic application |
| 05/03/2001 | CA2388934A1 Micro-cluster liquids and methods of making and using them |
| 05/03/2001 | CA2388924A1 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 05/03/2001 | CA2388535A1 Ligand activated transcriptional regulator proteins |